Drug Patents owned by Noden Pharma

1. List of Tekturna drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617595 NODEN PHARMA Galenic formulations of organic compounds
Feb, 2026

(3 years from now)

US8617595

(Pediatric)

NODEN PHARMA Galenic formulations of organic compounds
Aug, 2026

(3 years from now)

Drugs and Companies using ALISKIREN HEMIFUMARATE ingredient

Market Authorisation Date: 05 March, 2007

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of TEKTURNA before it's patent expiration?
More Information on Dosage

2. List of Tekturna Hct drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9023893 NODEN PHARMA Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
Mar, 2022

(11 months ago)

US8618172 NODEN PHARMA Galenical formulations of organic compounds
Jul, 2028

(5 years from now)

Drugs and Companies using ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE ingredient

Market Authorisation Date: 18 January, 2008

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of TEKTURNA HCT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic